Scientech Research’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Scientech Research's ALNY Position: Q1 2026 in Review
Scientech Research sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 676 shares — an estimated $269K sold.
Scientech Research first reported a position in ALNY in Q1 2024 and held it in 4 quarters. The position peaked at $1.77M in Q3 2025. 799 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.
- Scientech Research reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Scientech Research sold 676 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $269K.
- Scientech Research first reported a position in Alnylam Pharmaceuticals in Q1 2024 and held it in 4 quarters.
- Scientech Research's Alnylam Pharmaceuticals position peaked at $1.77M in Q3 2025.
- 799 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.
Based on Scientech Research's 13F filing for Q1 2026, filed 15 May 2026.